Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan-Mar;3(1):3-9.

Spinal muscular atrophy disease: a literature review for therapeutic strategies

M Stavarachi  1 , P Apostol, M Toma, D Cimponeriu, L Gavrila
Affiliations
Review

Spinal muscular atrophy disease: a literature review for therapeutic strategies

M Stavarachi et al. J Med Life. 2010 Jan-Mar.

Abstract

Currently, there is no cure for the treatment of spinal muscular atrophy (SMA). Based on the available clinical and molecular findings, different therapeutic strategies were tested in vitro and in vivo and clinical trials are ongoing. The main therapeutic direction is focused on the enhancement of SMN expression by increasing the full-length (fl) SMN2 transcript levels, preventing the SMN exon 7 from skipping or from protein stabilizing. In addition, the action of neurotrophic, neuroprotective or anabolic agents is tested and stem cell and gene therapy approaches are in a promising development.

PubMed Disclaimer

References

    1. Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. Journal of Medical Genetics. 1978;5:409–413. - PMC - PubMed
    1. Melki J, Lefebvre S, Burglen L, Burlet P, Clermont O, Millasseau P, Reboullet S, Benichou B, Zeviani M, LePaslier D. De novo and inherited deletions of 5q13 region in spinal muscular atrophies . Science. 1994;264:1474–1477. - PubMed
    1. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiology of Disease. 1996;3:97–110. - PubMed
    1. Kaplan JC. Gene table of monogenic neuromuscular disorders (nuclear genome only) Neuromuscular Disorders. 2009;19:77–98. - PubMed
    1. Dubowitz V. Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype . European Journal of Paediatric Neurology. 1999;3:49–51. - PubMed

MeSH terms

LinkOut - more resources